Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank100
3Y CAGR+4.5%
5Y CAGR+3.1%
Year-over-Year Change
Quality of reported income
3Y CAGR
+4.5%/yr
vs +7.1%/yr prior
5Y CAGR
+3.1%/yr
Consistent
Acceleration
-2.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.09 | +44.1% |
| 2024 | 0.76 | +156.6% |
| 2023 | 0.29 | -69.2% |
| 2022 | 0.96 | +17.1% |
| 2021 | 0.82 | -12.9% |
| 2020 | 0.94 | +11.6% |
| 2019 | 0.84 | +15.6% |
| 2018 | 0.73 | -19.7% |
| 2017 | 0.90 | +4.1% |
| 2016 | 0.87 | - |